Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Curley

Showing results (51-60 of 97) with videos related to

Pageof 10
Sort By:
Journal of Carbohydrate Chemistry|June 20, 2017
Improved Synthesis of the <i>C</i>-Glucuronide/Glycoside of 4-Hydroxybenzylretinone (4-HBR)Kathryn R Cavanaugh, Sureshbabu Narayanasamy, Joel R Walker, et al.
The Journal of Laryngology and Otology|February 1, 1991
Otogenic Fusobacterium necrophorum meningitisA Pace-Balzan, A O Keith, J W Curley, et al.
Nutrition and Cancer|January 11, 1992
Effect of dietary soybean and licorice on the male F344 rat: an integrated study of some parameters relevant to cancer chemopreventionT E Webb, P C Stromberg, H Abou-Issa, et al.
The Journal of Biological Chemistry|May 6, 2011
Identification of dihydroceramide desaturase as a direct in vitro target for fenretinideMehrdad Rahmaniyan, Robert W Curley, Lina M Obeid, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 6, 2008
4-Hydroxyphenylretinamide (4HPR) derivatives regulate aromatase activity and expression in breast cancer cellsBin Su, Serena M Mershon, Laura A Stonerock, et al.
Archives of Biochemistry and Biophysics|November 1, 2003
Hydrolysis of 4-HPR to atRA occurs in vivo but is not required for retinamide-induced apoptosisJason S Chapman, Kevin L Weiss, Robert W Curley, et al.
Anticancer Research|August 1, 2018
4-HPR Is an Endoplasmic Reticulum Stress Aggravator and Sensitizes Breast Cancer Cells Resistant to TRAIL/Apo2LAllyson L Anding, James D Jones, Michael A Newton, et al.
Anticancer Research|September 1, 1993
In vivo use of N-(4-hydroxyphenyl retinamide)-0-glucuronide as a breast cancer chemopreventive agentH Abou-Issa, R W Curley, M J Panigot, et al.
Synthesis|January 26, 2013
Efficient, Low-Cost Synthesis of Retinal (Vitamin A Aldehyde)Damian P Hruszkewycz, Kathryn R Cavanaugh, Kathryn T Takamura, et al.
Cancer Research|July 10, 2007
The unhydrolyzable fenretinide analogue 4-hydroxybenzylretinone induces the proapoptotic genes GADD153 (CHOP) and Bcl-2-binding component 3 (PUMA) and apoptosis that is caspase- dependent and independent of the retinoic acid receptorAllyson L Anding, Jason S Chapman, Derek W Barnett, et al.
Pageof 10

Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
Journal of Carbohydrate Chemistry|June 20, 2017
Improved Synthesis of the <i>C</i>-Glucuronide/Glycoside of 4-Hydroxybenzylretinone (4-HBR)Kathryn R Cavanaugh, Sureshbabu Narayanasamy, Joel R Walker, et al.
The Journal of Laryngology and Otology|February 1, 1991
Otogenic Fusobacterium necrophorum meningitisA Pace-Balzan, A O Keith, J W Curley, et al.
Nutrition and Cancer|January 11, 1992
Effect of dietary soybean and licorice on the male F344 rat: an integrated study of some parameters relevant to cancer chemopreventionT E Webb, P C Stromberg, H Abou-Issa, et al.
The Journal of Biological Chemistry|May 6, 2011
Identification of dihydroceramide desaturase as a direct in vitro target for fenretinideMehrdad Rahmaniyan, Robert W Curley, Lina M Obeid, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 6, 2008
4-Hydroxyphenylretinamide (4HPR) derivatives regulate aromatase activity and expression in breast cancer cellsBin Su, Serena M Mershon, Laura A Stonerock, et al.
Archives of Biochemistry and Biophysics|November 1, 2003
Hydrolysis of 4-HPR to atRA occurs in vivo but is not required for retinamide-induced apoptosisJason S Chapman, Kevin L Weiss, Robert W Curley, et al.
Anticancer Research|August 1, 2018
4-HPR Is an Endoplasmic Reticulum Stress Aggravator and Sensitizes Breast Cancer Cells Resistant to TRAIL/Apo2LAllyson L Anding, James D Jones, Michael A Newton, et al.
Anticancer Research|September 1, 1993
In vivo use of N-(4-hydroxyphenyl retinamide)-0-glucuronide as a breast cancer chemopreventive agentH Abou-Issa, R W Curley, M J Panigot, et al.
Synthesis|January 26, 2013
Efficient, Low-Cost Synthesis of Retinal (Vitamin A Aldehyde)Damian P Hruszkewycz, Kathryn R Cavanaugh, Kathryn T Takamura, et al.
Cancer Research|July 10, 2007
The unhydrolyzable fenretinide analogue 4-hydroxybenzylretinone induces the proapoptotic genes GADD153 (CHOP) and Bcl-2-binding component 3 (PUMA) and apoptosis that is caspase- dependent and independent of the retinoic acid receptorAllyson L Anding, Jason S Chapman, Derek W Barnett, et al.
Pageof 10